GoodRx (GDRX)
(Delayed Data from NSDQ)
$4.50 USD
-0.03 (-0.66%)
Updated Aug 4, 2025 04:00 PM ET
After-Market: $4.50 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth C Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/06/2025
Time: AMC |
6/2025 | $0.10 | 0.00% |
Earnings Summary
For their last quarter, GoodRx (GDRX) reported earnings of $0.09 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for GDRX's next earnings release on August 06, 2025. For the next earning release, we expect the company to report earnings of $0.10 per share, reflecting a year-over-year increase of 25%.
Earnings History
Price & Consensus
Zacks News for GDRX
GDRX vs. HQY: Which Stock Is the Better Value Option?
GDRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
DOCS Boosts Client Retention via Workflow Integration and AI Tools
The Zacks Analyst Blog Highlights Sprouts Farmers Market, DexCom, Hims & Hers Health, United Natural Foods and GoodRx
Buy 5 Health and Fitness Stocks to Enhance Your Portfolio Returns
GDRX FAQs
GoodRx Holdings, Inc. (GDRX) has announced they will report their next quarter earnings on August 06, 2025. For the next earning release, we expect the company to report earnings of $0.10 per share, reflecting a year-over-year increase of 25.00%.
GoodRx Holdings, Inc. has announced they will report their previous quarter earnings after the close of the market on August 06, 2025.
The Zacks Consensus Estimate for GoodRx Holdings, Inc. (GDRX) for the quarter ending June 2025 is $0.10 a share. We expect GoodRx Holdings, Inc. (GDRX) to report earnings in line with the consensus estimate of $0.10 per share
In the earnings report for the quarter ending in June 2024, GoodRx Holdings, Inc. (GDRX) announced earnings of $0.08 per share versus the Zacks Consensus Estimate of $0.09 per share, representing a surprise of -11.11%.